Press release
Beta-Secretase Inhibitors Pipeline - Key Players Analysis Eli Lilly and Company, AstraZeneca, Johnson & Johnson
Browse report sample at: https://www.psmarketresearch.com/market-analysis/beta-secretase-inhibitors-pipeline-analysis/report-sample
*Insights on pipeline segments
As per the findings of the research, most of the pipeline drug candidates of BACE inhibitors are being developed to be administered by oral route.
*Alzheimer’s disease drug development receives Fast Track designation
Among BACE inhibitors, AZD3293, a drug candidate of AstraZeneca plc and Eli Lilly and Company, received Fast Track designation by the U.S. Food and Drug Administration (FDA) in August 2016. The FDA’s Fast Track program was designed to expedite the development and review new therapies to treat serious conditions and tackle unmet medical needs.
Browse report at: https://www.psmarketresearch.com/market-analysis/beta-secretase-inhibitors-pipeline-analysis
*Major companies collaborate for the development of BACE inhibitors
The research finds that different companies collaborated for the development of BACE inhibitors. Novartis entered in a global collaboration with Amgen to commercialize and develop BACE inhibitor program in September 2015 for Alzheimer's disease.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=beta-secretase-inhibitors-pipeline-analysis
Some of the key players developing BACE inhibitors are AstraZeneca plc, Eli Lilly & Company, Johnson & Johnson, and others.
About P&S Intelligence
P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Beta-Secretase Inhibitors Pipeline - Key Players Analysis Eli Lilly and Company, AstraZeneca, Johnson & Johnson here
News-ID: 1433659 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for BACE
Recycling Compactors Market Growth Rate, Demands, Price, Revenue, Drivers, Share …
Recycling Compactors Market research report highlights key business needs to help organizations to realign their business systems. It also offers the fundamental discoveries and proposals that feature vital reformist industry patterns in the Recycling Compactors industry, subsequently allowing players across the supply chain to foster effective long-haul systems. In addition, It Provides comprehensive information on the evolution of the market offered by the key manufacturers.
Request a Free PDF Sample of…
Recycling Compactors Market Size, Growth and SWOT Analysis by Key Players: BACE, …
The report offers in-depth analysis of the global Recycling Compactor market taking into account market dynamics, segmentation, geographical expansion, competitive landscape, and various other key aspects. The market analysts who have prepared the report have thoroughly studied the global Recycling Compactor market and have offered reliable and accurate data. They understand the needs of the industry and the clients, which makes it easy for them to focus on the aspects,…
Pharma News: BACE Inhibitors Pipeline Analysis - AstraZeneca, Eli Lilly and Comp …
The study analysed that the Beta Secretase inhibitors pipeline comprised 15 drug candidates, in different stages of development.
Browse report sample at: https://www.psmarketresearch.com/market-analysis/beta-secretase-inhibitors-pipeline-analysis/report-sample
Insights on pipeline segments
As per the findings of the research, most of the pipeline drug candidates of BACE inhibitors are being developed to be administered by oral route.
Alzheimer’s disease drug development receives Fast Track designation
Among BACE inhibitors, AZD3293, a drug candidate of AstraZeneca plc and Eli Lilly and Company,…
2019-2025 Rising demands of Global Clay Pipe Market Trends Major Key Companies M …
UpMarketResearch offers a latest published report on “Global Clay Pipe Market Analysis and Forecast 2019-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 115 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/46566
Clay Pipe Market research report delivers a close watch…
BACE Inhibitors Pipeline to Witness Huge R&D Investment in the Coming Years
The study analysed that the Beta Secretase inhibitors pipeline comprised 15 drug candidates, in different stages of development.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/beta-secretase-inhibitors-pipeline-analysis
As per the findings of the research, most of the pipeline drug candidates of BACE inhibitors are being developed to be administered by oral route.
Among BACE inhibitors, AZD3293, a drug candidate of AstraZeneca plc and Eli Lilly and Company, received Fast Track designation by the U.S. Food and…
BACE Inhibitors Exhibit an Emerging Pipeline with 10+ Drug Candidates
BACE inhibitors offer novel therapeutic approach for the treatment of Alzheimer’s disease
The study analyzed that the Beta Secretase inhibitors pipeline comprised 15 drug candidates, of which three products are in Phase III, three products in Phase II, one product in Phase I, and one product is in Discovery. The development of two BACE inhibitor candidates was found to be inactive, and five products were discontinued. BACE is a cleaving enzyme…
